Ind-Swift Laboratories Share Price
Know More₹80.54-5.72 (-6.63%)
25-Apr-2025₹80.51-5.29 (-6.17%)
25-Apr-2025BSE : 532305
NSE : INDSWFTLAB
Sector : Health care
ISIN Code : INE915B01019
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 25-Apr-2025
| Market Cap (₹ Cr) | 488 |
Traded Value (₹ Cr) | 0.19 |
Volume (Shares) | 23,333 |
Face Value (₹) | 10 |
52-Week High (₹) | 186.00 |
52-Week High Date | 02-Aug-2024 |
52-Week Low (₹) | 74.00 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 297.35 |
All Time High Date | 22-Dec-2004 |
All Time Low (₹) | 13.25 |
All Time Low Date | 31-Mar-2003 |
Ind-Swift Laboratories Ltd
Market News
Ind-Swift Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 488 |
| EPS - TTM (₹) [C] | 13.65 |
| P/E Ratio (X) [C] | 5.90 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 20-Sep-2011 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 169.93 |
| P/B Ratio (₹) [C] | 0.47 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 343 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 80.00 87.49 |
| Week Low/High (₹) | 80.00 93.00 |
| Month Low/High (₹) | 80.00 95.00 |
| Year Low/High (₹) | 80.00 186.00 |
| All time Low/High (₹) | 13.25 297.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -7.52% | 28.86% | 0.84% | 0.79% |
| 1 Month | -9.35% | 26.84% | 1.53% | 1.57% |
| 3 Month | -27.47% | 1.89% | 3.97% | 4.10% |
| 6 Month | -29.90% | -2.75% | -0.24% | -0.58% |
| 1 Year | -35.29% | -9.73% | 6.56% | 6.51% |
| 3 Year | 17.96% | 64.83% | 40.00% | 41.79% |
Company Info
Company Information
Chairman & Managing Director : N R Munjal
Joint Managing Director : Himanshu Jain
Company Sec. & Compli. Officer : Pradeep Verma
Executive Director : Rishav Mehta
Independent Director : S P Sharma
Independent Director : Neerja Chathley
Independent Director : Ashwani K Vig
Executive Director : Sahil Munjal
Independent Director : Rajendra Kumar Gupta
Independent Director : Param Bir Singh
Registered Office: SCO 850 Shivalik Enclave, NAC Manimajra,Chandigarh,Chandigarh-160101 Ph: 91-0172-5061850/2730920
FAQs about Ind-Swift Laboratories Ltd
1. What's the Ind-Swift Laboratories Ltd share price today?
Ind-Swift Laboratories Ltd share price was Rs 80.54 at close on 25th Apr 2025. Ind-Swift Laboratories Ltd share price was down by 6.63% from the previous closing price of Rs 86.26. Ind-Swift Laboratories Ltd share price trend:
- Last 1 Month: Ind-Swift Laboratories Ltd share price moved down by 9.35% on BSE.
- Last 3 Months: Ind-Swift Laboratories Ltd share price moved down by 27.47% on BSE.
- Last 12 Months: Ind-Swift Laboratories Ltd share price moved down by 35.29% on BSE.
- Last 3 Years: Ind-Swift Laboratories Ltd share price moved up by 17.96% on BSE.
2. How can I quickly analyse the performance of the Ind-Swift Laboratories Ltd stock?
The performance of the Ind-Swift Laboratories Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 5.90
- Price to book value ratio is 0.47
- The EPS (trailing 12 months) of the Ind-Swift Laboratories Ltd stock is Rs 13.65
3. What is the market cap of Ind-Swift Laboratories Ltd?
Ind-Swift Laboratories Ltd has a market capitalisation of Rs 488 crore.
4. What is Ind-Swift Laboratories Ltd's 52-week high/low share price?
The Ind-Swift Laboratories Ltd’s 52-week high share price is Rs 186.00 and 52-week low share price is Rs 74.00.
5. Is the Ind-Swift Laboratories Ltd profitable?
On a consolidated basis, Ind-Swift Laboratories Ltd reported a loss of Rs -0.01 crore on a total income of Rs 22.48 crore for the quarter ended 2024. For the year ended 2024, Ind-Swift Laboratories Ltd had posted a profit of Rs 421.45 crore on a total income of Rs 1,280.90 crore.
6. Which are Ind-Swift Laboratories Ltd’s peers in the Health care sector?
Ind-Swift Laboratories Ltd’s top 5 peers in the Health care sector are Kilitch Drugs, Megasoft, Nectar Lifesci., Ind-Swift Labs., Albert David, Jenburkt Pharma, Medico Remedies.
7. Who owns how much in Ind-Swift Laboratories Ltd?
Key changes to the Ind-Swift Laboratories Ltd shareholding are as follows:
- Promoter holding in Ind-Swift Laboratories Ltd has gone down to 40.94 per cent as of Mar 2025 from 42.00 per cent as of Sep 2024.
